Insider · CIK 0001380187
Daniel Abdun-Nabi
Files at APVO (Aptevo Therapeutics Inc.). First filing -, latest -.
In brief
Daniel Abdun-Nabi files SEC Form 4 as director at APVO (Aptevo Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Daniel Abdun-Nabi has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +400 | - | - | 400 | Aug 10, 2026 |
| Aug 6, 2026 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -400 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Aug 6, 2025 | APVO Aptevo Therapeutics Inc. | AGrant or award Restricted Stock Unitderivative | +7,200 | $0.00 | $0 | 7,200 | Aug 8, 2025 |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +1 | - | - | 1 | Jul 21, 2025 |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -1 | $0.00 | $0 | 0 | Jul 21, 2025 |
Questions about Daniel Abdun-Nabi
Answered from the filings on this page, as of the latest one.
Is Daniel Abdun-Nabi buying or selling?
Daniel Abdun-Nabi has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Daniel Abdun-Nabi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel Abdun-Nabi has 0.
Where does Daniel Abdun-Nabi file Form 4?
Daniel Abdun-Nabi has filed Form 4 at APVO (Aptevo Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.